Element Pointe Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Element Pointe Advisors, LLC

  • $411 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $620,732 - $836,366
-1,132 Closed
0 $0
Q1 2022

May 11, 2022
SELL
$595.12 - $698.43 $249,355 - $292,642
-419 Reduced 27.01%
1,132 $791,000
Q4 2021

Feb 08, 2022
BUY
$543.48 - $670.97 $107,609 - $132,852
198 Added 14.63%
1,551 $979,000
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $776,662 - $921,338
1,353 New
1,353 $819,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Element Pointe Advisors, LLC Portfolio

Follow Element Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Pointe Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email